Discover the latest news and events from Medis
QFR® as a new tool for the assessment of non-culprit lesions in ACS In the interview series ‘Medis 1 on 1’, prof. Hans Reiber (CSO, Medis Medical Imaging) interviews a
QFR® identified additional lesions at risk for future nontarget vessel–related events in STEMI through 5 years of follow up. Dr Sarah Bär et al from Univ of Bern, Switzerland carried
In a recent prospective study in 421 patients, the fluoroscopy time (FT) was measured. With QFR® the FT was only 47% of that of FFR and 30% of iFR. QFR®
At Medis we believe that QFR® is the future in angiography, QFR® is a non-non-invasive angiography based physiologic assessment of the presence and extent of coronary artery disease. QFR® provides
Medis is proud to be recognized for its MR Atrial Strain solution, which was found to be at par with the Ultrasound Atrial Strain solution (AMID/Medis); this last one is regarded as the gold standard in
Leiden, The Netherlands – May 7, 2020 MEDIS MEDICAL IMAGING SYSTEMS ACQUIRES AMID AND SECURES FURTHER INVESTMENT FROM VAN HERK VENTURES MEDIS, a leading developer and supplier of software applications for image-based
The next step for non-invasive angiography in the United States and CanadaWe are proud to announce our formal distribution partnership with ACIST to co-market QFR® in the United States and Canada.
Recently Dr Simone Biscaglia and colleagues of the team of Prof Gianluca Campo published this very important paper in JACC interventions. A total of 751 vessels in 602 patients were
The ITEA project BENEFIT aimed to support clinicians in selecting the optimal diagnostic and treatment pathway for patients. As a first, a procedure called QFR® (Quantitative Flow Ratio) analysis was developed by
It has been a month since we invited people to the QFR Visual Interpretation Challenge during the EuroPCR 2021. Over 400 participants participated in the QFR Visual Interpretation Challenge. Below we
Are you curious about QFR®? Then this message is for you!Our new QFR® video is out!Check it out at https://youtu.be/38UMru01bIs
The ITEA project BENEFIT aimed to support clinicians in selecting the optimal diagnostic and treatment pathway for patients. Medis’ innovative software, QFR® is used in the study. Read more here.